AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.260
+0.007 (2.73%)
Oct 31, 2024, 4:00 PM EDT - Market closed
AIM ImmunoTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.2 | 0.2 | 0.14 | 0.14 | 0.16 | 0.14 | Upgrade
|
| Revenue Growth (YoY) | 19.64% | 43.26% | 4.44% | -17.18% | 16.43% | -61.85% | Upgrade
|
| Cost of Revenue | 0.06 | 0.04 | - | 0.85 | 0.81 | 0.89 | Upgrade
|
| Gross Profit | 0.14 | 0.16 | 0.14 | -0.72 | -0.64 | -0.75 | Upgrade
|
| Selling, General & Admin | 23.13 | 21.64 | 13.29 | 8.67 | 8.65 | 7.04 | Upgrade
|
| Research & Development | 8.6 | 10.44 | 6.77 | 7.67 | 5.56 | 4.65 | Upgrade
|
| Operating Expenses | 31.73 | 32.08 | 20.06 | 16.34 | 14.22 | 11.69 | Upgrade
|
| Operating Income | -31.59 | -31.92 | -19.92 | -17.06 | -14.86 | -12.44 | Upgrade
|
| Interest Expense | -0.25 | - | - | -0.07 | -0.67 | -0.43 | Upgrade
|
| Interest & Investment Income | 3.21 | 1.07 | 0.63 | - | - | 0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.63 | 1.67 | 1.53 | 2.46 | 1.06 | 2.42 | Upgrade
|
| EBT Excluding Unusual Items | -28 | -29.18 | -17.77 | -14.66 | -14.47 | -10.37 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | 0.2 | -1.68 | -0.2 | 0.22 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | 0.02 | 0 | 0.22 | - | - | Upgrade
|
| Asset Writedown | - | - | - | -1.78 | -0.29 | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | 1.22 | Upgrade
|
| Other Unusual Items | - | - | - | -2.7 | 0.14 | -0.26 | Upgrade
|
| Pretax Income | -28.05 | -28.96 | -19.45 | -19.13 | -14.4 | -9.4 | Upgrade
|
| Net Income | -28.05 | -28.96 | -19.45 | -19.13 | -14.4 | -9.4 | Upgrade
|
| Net Income to Common | -28.05 | -28.96 | -19.45 | -19.13 | -14.4 | -9.4 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 49 | 48 | 47 | 32 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 49 | 48 | 47 | 32 | 4 | Upgrade
|
| Shares Change (YoY) | 3.57% | 1.12% | 1.49% | 48.67% | 774.15% | 262.71% | Upgrade
|
| EPS (Basic) | -0.56 | -0.60 | -0.40 | -0.40 | -0.45 | -2.58 | Upgrade
|
| EPS (Diluted) | -0.56 | -0.60 | -0.40 | -0.40 | -0.45 | -2.58 | Upgrade
|
| Free Cash Flow | -23.25 | -21.27 | -16.19 | -14.01 | -10.39 | -9.14 | Upgrade
|
| Free Cash Flow Per Share | -0.47 | -0.44 | -0.34 | -0.30 | -0.33 | -2.51 | Upgrade
|
| Gross Margin | 71.14% | 79.21% | 100.00% | - | - | - | Upgrade
|
| Operating Margin | -15715.92% | -15800.00% | -14129.79% | -12636.30% | -9115.95% | -8887.86% | Upgrade
|
| Profit Margin | -13952.74% | -14337.62% | -13790.78% | -14168.15% | -8834.36% | -6717.14% | Upgrade
|
| Free Cash Flow Margin | -11568.16% | -10528.22% | -11485.11% | -10374.81% | -6374.23% | -6525.00% | Upgrade
|
| EBITDA | -31.36 | -31.68 | -19.67 | -16.28 | -14.13 | -11.65 | Upgrade
|
| D&A For EBITDA | 0.23 | 0.24 | 0.26 | 0.78 | 0.73 | 0.79 | Upgrade
|
| EBIT | -31.59 | -31.92 | -19.92 | -17.06 | -14.86 | -12.44 | Upgrade
|
| Revenue as Reported | 0.2 | 0.2 | 0.14 | 0.14 | 0.16 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.